MedCity News October 25, 2022
Robin Farmanfarmaian

Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company’s medication by their physician.

The U.S. healthcare industry has adopted the basic phone call, video call, and email with a healthcare professional as telemedicine. But telemedicine extends significantly farther than the synchronous healthcare delivery of a phone call or video session. Any type of software, connected device, or treatment prescribed and monitored by a healthcare professional and accessed by patients in their daily lives can be considered telemedicine, sometimes referred to as asynchronous telemedicine or virtual care.

Clinical trials are typically the only time a pharmaceutical company has direct insight into the individuals who use their medication. Once a medication is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Technology, Telehealth
How AI is streamlining cell and gene therapy manufacturing
Kroger partners with Express Scripts to expand pharmacy services
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
Vertex challenger Sionna prices $191M IPO
Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025?

Share This Article